Unknown

Dataset Information

0

Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling.


ABSTRACT: Background: Recent evidence indicates that host-gut microbiota crosstalk has nonnegligible effects on host skeletal muscle, yet gut microbiota-regulating mechanisms remain obscure.Methods: C57BL/6 mice were treated with a cocktail of antibiotics (Abx) to depress gut microbiota for 4 weeks. The profiles of gut microbiota and microbial bile acids were measured by 16S rRNA sequencing and ultra-performance liquid chromatography (UPLC), respectively. We performed qPCR, western blot and ELISA assays in different tissue samples to evaluate FXR-FGF15/19 signaling.Results: Abx treatment induced skeletal muscle atrophy in mice. These effects were associated with microbial dysbiosis and aberrant bile acid (BA) metabolism in intestine. Ileal farnesoid X receptor (FXR)-fibroblast growth factor 15 (FGF15) signaling was inhibited in response to microbial BA disturbance. Mechanistically, circulating FGF15 was decreased, which downregulated skeletal muscle protein synthesis through the extracellular-signal-regulated protein kinase 1/2 (ERK1/2) signaling pathway. Treating Abx mice with FGF19 (human FGF15 ortholog) partly reversed skeletal muscle loss.Conclusions: These findings indicate that the BA-FXR-FGF15/19 axis acts as a regulator of gut microbiota to mediate host skeletal muscle.

SUBMITTER: Qiu Y 

PROVIDER: S-EPMC8018554 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10822858 | biostudies-literature
| S-EPMC4164778 | biostudies-literature
| S-EPMC4092213 | biostudies-literature
| S-EPMC6478420 | biostudies-literature
| S-EPMC8061369 | biostudies-literature
| S-EPMC6744452 | biostudies-literature
| S-EPMC8076524 | biostudies-literature
| S-EPMC6104110 | biostudies-literature
| S-EPMC9410481 | biostudies-literature
| S-EPMC4537692 | biostudies-literature